Hexagon Technology is pleased to announce that it is opening offices in China, and further expanding its operations in India and Singapore. Total employee headcount for Hexagon Technology has now reached some 350 persons, and Hexagon Technology is now ranked … Continue reading
Medgenics (LON:MEDG) unveiled what it described as encouraging early data from the phase IIa clinical trial of its potentially revolutionary EPODURE Biopump device. It is currently being used to deliver erythropoietin, known as EPO for short, to anaemic pre-dialysis patients … Continue reading
Data will be used to support Phase II trial in U.S. Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of Biopump?, a novel technology for the sustained production and delivery of therapeutic proteins in patients using … Continue reading
SAN CARLOS, CA–(Marketwired – Apr 22, 2013) - Check Point® Software Technologies Ltd. (NASDAQ: CHKP), the worldwide leader in securing the Internet, today announced its financial results for the first quarter ending March 31, 2013. Total Revenue: $322.7 million, representing a 3 percent … Continue reading
Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of Biopump?, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced the United States Patent and … Continue reading
Medgenics Inc. reached the higher end of its ambitions in an issue of stocks and warrants, raising $30 million to provide funding for further clinical development of its Biopump protein drug implant technology.
Former Prime Minister, Ehud Olmert, received shares in the company. Olmert will support the company in business development and investor relations.